Capricor Therapeutics

dynamic arrows moving up

Biotech

Capricor sets up 2nd DMD approval attempt with ph. 3 win

The results mimic those of prior phase 2 studies, which Capricor used to seek approval of deramiocel last year only to be rejected by the FDA.

Darren Incorvaia Dec 3, 2025 11:11am

Manila folder with CONFIDENTIAL printed on it in red

Capricor responds to cell therapy snub, disputes FDA’s concerns

Sep 9, 2025 11:44am

FDA

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm

Graphic image of a red thumbs down against a blue background

FDA rejects Capricor’s DMD cell therapy, asks for more data

Jul 11, 2025 9:18am

Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS oncology head swings to Syndax—Chutes & Ladders

May 16, 2025 8:30am

Duchenne muscular dystrophy DMD

Capricor shares turn red as FDA announces deramiocel adcomm plan

May 6, 2025 8:32am